ACS Chemical Neuroscience

ACS Chemical Neuroscience is a peer-reviewed scientific journal published by the American Chemical Society. It covers original research on the molecular underpinnings of nerve function in organisms and animal models. The journal was established in September, 2009, ahead of the publication of the first issue in January 2010. The journal is one of the first journals of the American Chemical Society to be available in online-only format. The founding editor in chief is Craig W. Lindsley (Vanderbilt University). Notable authors include Joanna S. Fowler, Nora Volkow, and P. Jeffrey Conn. ACS Chemical Neuroscience publishes research letters, articles, and reviews that all are peer-reviewed. In addition, specially commissioned articles that describe journal content and advances in neuroscience are solicited from leaders in the field. Because of the online-only format, researchers can use functionalities available only on the web. The journal presents research dealing with diverse topics covering all areas of neuroscience such as neural development, plasticity, and degeneration; molecular and chemical analysis of neurotransmitters and receptors; design and development of pharmaceuticals

Publisher
American Chemical Society ACS Publications
Country
United States
History
2010–present

Some content from Wikipedia, licensed under CC BY-SA

Neuroscience

Scientists discover powerful potential pain reliever

A team of scientists led by chemists Stephen Martin and James Sahn at The University of Texas at Austin have discovered what they say is a powerful pain reliever that acts on a previously unknown pain pathway. The synthetic ...

Psychology & Psychiatry

New study throws into question long-held belief about depression

New evidence puts into doubt the long-standing belief that a deficiency in serotonin—a chemical messenger in the brain—plays a central role in depression. In the journal ACS Chemical Neuroscience, scientists report that ...

Neuroscience

How a popular antidepressant drug could rewire the brain

Prozac, the trade name for the drug fluoxetine, was introduced to the U.S. market for the treatment of depression in 1988. Thirty years later, scientists still don't know exactly how the medication exerts its mood-lifting ...

Neuroscience

A first: Brain support cells from umbilical cord stem cells

For the first time ever, stem cells from umbilical cords have been converted into other types of cells, which may eventually lead to new treatment options for spinal cord injuries and multiple sclerosis, among other nervous ...

Psychology & Psychiatry

Psychedelic microdosing in rats shows beneficial effects

The growing popularity of microdosing—taking tiny amounts of psychedelic drugs to boost mood and mental acuity—is based on anecdotal reports of its benefits. Now, a study in rats by researchers at the University of ...

Neuroscience

Investigating how 'chemo brain' develops in cancer patients

During and after chemotherapy, many cancer patients describe feeling a mental fog, a condition that has been dubbed "chemo brain." Why this happens is unclear, but researchers have found a new clue to understanding this syndrome. ...

page 1 from 3